CIB vs IFS: How Grupo Cibest and Intercorp Financial Services Compare (2026)

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CIB and IFS share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CIB and IFS exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Grupo Cibest is the holding company created in May 2025 to sit above Bancolombia, and the NYSE ticker CIB still trades under the old name in a lot of data feeds. Bancolombia itself is the largest bank in Colombia by assets, with roughly COP 262 trillion (about $82 billion) of gross loans and COP 272 trillion of customer deposits as of the first quarter of 2026. Around it sits a group that is broader than one bank: Nequi, the mobile wallet that has passed 27 million users and is working toward its own separate license, the Wompi payments business, Renting Colombia, Banco Agricola in El Salvador and BAM in Guatemala. The Panamanian subsidiary Banistmo was agreed for sale at about $1.4 billion and the deal was set to close in the second quarter of 2026, which simplifies the group and frees capital for the digital businesses.

Full CIB guide

Intercorp Financial Services is one of Peru's largest financial groups and reports in three segments. Interbank is the banking business and the bulk of earnings, running retail and commercial lending, deposits, cards and payments through a national branch and digital network. Interseguro is the insurance arm, weighted toward annuities and life products, which makes it sensitive to interest rates and to the reserves it holds against long-dated liabilities. Inteligo is the wealth management business, managing assets for high net worth Peruvian clients and earning fee income that is steadier than lending spreads. The parent is part of the wider Intercorp group, a Peruvian conglomerate with interests spanning retail, education and real estate, and the shares list on both the NYSE and the Lima exchange.

Full IFS guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• CIB drivers: A rate cycle running in the bank's favor; Nequi and the shift toward fee income.
• IFS drivers: Peruvian credit cycle normalisation; Interseguro and the annuity book.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The single largest risk is that everything here is priced in a currency the ADR holder does not control: a peso that weakens back toward the 4,000 per dollar levels of 2024 would cut reported dividends and share price in dollars even if the bank performs exactly as guided. For IFS, country concentration is the dominant risk: essentially all of the group's earnings are Peruvian, and Peru has produced repeated political instability, presidential turnover and periodic pension withdrawal legislation that alters savings behaviour overnight.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick CIB if you believe its drivers more; IFS if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CIB and IFS guides.

CIB. The trailing numbers are misleading and it is worth separating them from the run rate. Fourth-quarter 2025 carried a non-cash goodwill impairment on the Banistmo sale that dragged trailing twelve-month return on equity down to about 7.65%, while the first quarter of 2026 annualized to roughly 14.9% at the group and about 19% at Bancolombia standalone. Full-year 2026 guidance of 19.5% to 20% return on equity is what the forward multiple near 8.5 times is discounting, and second-quarter results were due around August 10, 2026.

IFS. IFS reports in Peruvian soles while the NYSE line trades in US dollars, so every ratio above depends on which currency the denominator is in. First quarter 2026 profit of roughly S/ 602 million was a record and up about 35% year over year, with management guiding to full year return on equity above 17%. The double digit earnings multiple sits below US regional bank averages, which is the standard emerging market discount rather than a comment on the quality of this quarter's results.

Headline figures (approximate, August 2026): CIB shows revenue (ttm) ~$6.6 billion, net income (q1 2026) ~COP 1.46 trillion (~$455 million), ~COP 1.8 trillion excluding the wealth tax, market cap ~$23.6 billion, forward p/e ~8.5x (trailing ~24x on impairment-distorted earnings); IFS shows total assets ~S/ 102 billion (~$29 billion), net income (trailing twelve months) ~$598 million (~S/ 2.1 billion), return on equity ~19% annualised in Q1 2026, market capitalisation ~$6.6 billion.

CIB and IFS are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined CIB and IFS exposure against your real portfolio. It is not an investment adviser.